Develop a biomarker-based test of cure (TOC) to evaluate treatment outcome during the chronic phase of chagas infection.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93021C00062
- Awardee
-
Kephera Diagnostics LLC UEI LJFNSE6NM648
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Contract value 100% obligated
- $300,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541713 Research and Development in Nanotechnology
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 6 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Framingham, MA 01702, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Original award | $300,000 |
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Phase I contract to Kephera Diagnostics LLC, a for-profit limited liability company, to develop a biomarker-based test of cure (TOC) to evaluate treatment outcome during the chronic phase of Chagas infection. The contract, a Definitive Contract with Firm Fixed Price pricing, has a potential value of $300,000.00 and a completion date of August 31, 2022. Kephera Diagnostics has prior experience providing in vitro diagnostics and biomarker tests for various neglected infectious diseases through federal grants and contracts.
Quick answers
Who was awarded contract 75N93021C00062?
75N93021C00062 was awarded to Kephera Diagnostics LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2021.
How much is contract 75N93021C00062 worth?
The government has obligated $300,000 on 75N93021C00062.
Was contract 75N93021C00062 competed?
The extent of competition for 75N93021C00062 was full and open competition after exclusion of sources. The government received 6 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award